301
Participants
Start Date
December 31, 2006
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
Engerix™-B Kinder
Intramuscular injection, 1 dose
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Trier
GSK Investigational Site, Trier
GSK Investigational Site, Gerolstein
GSK Investigational Site, Gau-Odernheim
GSK Investigational Site, Aschaffenburg
GSK Investigational Site, Schoeneberg - Kuebelberg
GSK Investigational Site, Frankenthal
GSK Investigational Site, Dudenhofen
GSK Investigational Site, Stuttgart
GSK Investigational Site, Oberstenfeld
GSK Investigational Site, Bietigheim-Bissingen
GSK Investigational Site, Bönnigheim
GSK Investigational Site, Pforzheim
GSK Investigational Site, Offenburg
GSK Investigational Site, Kehl
GSK Investigational Site, Ettenheim
GSK Investigational Site, Tuttlingen
GSK Investigational Site, Kirchzarten
GSK Investigational Site, Herbolzheim
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Olching
GSK Investigational Site, Tegernsee
GSK Investigational Site, Nördlingen
GSK Investigational Site, Tettnang
GSK Investigational Site, Bad Saulgau
GSK Investigational Site, Ehingen
GSK Investigational Site, Cham
GSK Investigational Site, Leipzig
Lead Sponsor
GlaxoSmithKline
INDUSTRY